Schon competitive analysis

Explore patent oppositions filed by Schon against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Feb 12, 2026
Patent NumberTitleApplicantOpposition Date
Manufacture Of A Crystalline Pharmaceutical ProductORIONJan 9, 2026
Crystal Form Of Ozanimod, Crystal Form Of Hydrochloride Thereof, And Preparation Method ThereforCRYSTAL PHARMACEUTICAL SUZHOUDec 23, 2025
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 16, 2025
Methods For Dose Initiation Of Aripiprazole TreatmentsOTSUKA PHARMACEUTICALJul 1, 2025
Solid State Forms Of Mavacamten And Process For Preparation ThereofASSIA CHEMICAL INDUSTRIESJun 17, 2025
An Anhydrous Pharmaceutical Composition For Maintenance Treatment Of PsoriasisLEO PHARMAFeb 17, 2025
Compositions For Treating Spinal Muscular AtrophyF HOFFMANN LA ROCHEDec 20, 2024
Device For Dispensing A Fluid Product, And Method For Filling And For Plugging SameAPTAR FRANCEDec 12, 2024
New UseNOVARTISJul 10, 2024
Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTISNov 30, 2023

Latest PTAB cases involving Schon

Discover the latest PTAB cases involving Schon, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Schon with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Feb 12, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
DR SCHON29 - - -
IT SEAL - 2 - -
NOVARTIS6424 - 21
NOVO NORDISK911019